A Randomized, Double-blind, Dose-escalating, Placebo-controlled Phase Ib Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis
Latest Information Update: 07 Nov 2023
At a glance
- Drugs VC 005 (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Jiangsu Vcare Pharmatech
Most Recent Events
- 01 Nov 2023 Status changed from recruiting to completed.
- 10 Aug 2023 Status changed from not yet recruiting to recruiting.
- 29 May 2023 New trial record